What is the optimal VTE prophylaxis for hospitalized patients with COVID-19?
Should we use a different dose in critically ill patients in the ICU? When should we consider intermediate-dose anticoagulation?
Answer from: Medical Oncologist at Academic Institution
At the moment, my personal recommendation, in general, is to follow the ASH guidelines. If the patient has cancer and other major comorbidities along with COVID-19, a discussion is warranted around adjusting the dose of anticoagulation to the presumed risk of VTE in the individual patient, unde...
Sign in or Register to read more